SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Meditech (MTCH) Viraplex - possible cancer treatment
MTCH 32.19+2.0%12:46 PM EDT

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mr.Manners who wrote (1)6/2/1998 9:04:00 PM
From: Elliot  Read Replies (1) of 39
 
I had purchased the stock at the beginning of May when the company announced the introduction of an over-the-counter herpes treatment. The main problem is the company did not have the funds to launch the product. So, the stock tanked.

Hopefully yesterday's report will put some life into Meditech's prospects. As with most early stage cancer drugs, use in humans is still a long way off.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext